Track topics on Twitter Track topics that are important to you
SanBio's US-based Phase 1/2a Clinical Trial of SB623 for the Treatment of Chronic Motor Deficit from Ischemic Stroke Was Addressed at an Event Held by California Institute for Regenerative Medicine (CIRM)
The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that the US-based...
SanBio Co. Ltd. acquired Tulane University's patent portfolio surrounding cell therapies derived from mesenchymal stem cells (MSCs; multipotent cells capable of self-renewing and differentiating into ...
SanBio Co., Ltd. and US subsidiary SanBio, Inc. conducted the following personnel transfers, effective October 1, 2018. 1. Transfer DetailsAkihiro Tsujimura will become a...
The patent portfolio includes technology discovered by Aline Betancourt, a researcher at Tulane University. Betancourt’s technology optimizes anti-inflammatory and pro-inflammatory functions of MSCs...
The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that
The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio Inc.) (TOKYO:4592) has updated part of its March 13, 2018 release “Update on Development Progress of Regenerative Cell M...
SanBio: Supplementary Information to the Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623
SanBio Co., Ltd. (representative: Keita Mori, headquarters: Chuo-ku, Tokyo; hereinafter SanBio) has agreed to enter into an equity and business alliance with CareNet, Inc. (repres...
SanBio is a regenerative medicine company with cell based products in various stages of research, development and clinical trials. Its proprietary cell based product, SB623, is be...
SanBio (TOKYO:4592) is a leading regenerative medical products company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research...
Through regular contact with our customers in the Benelux and Germany, Sanbio has been able to offer a wide range of biotechnology and research products in the field of immunology, pathology, molecula...
We have published hundreds of SanBio Co., Ltd. news stories on BioPortfolio along with dozens of SanBio Co., Ltd. Clinical Trials and PubMed Articles about SanBio Co., Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SanBio Co., Ltd. Companies in our database. You can also find out about relevant SanBio Co., Ltd. Drugs and Medications on this site too.
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...